OncoCyte Corporation
US ˙ NasdaqCM ˙ US68235C2061
DIESES SYMBOL IST NICHT MEHR AKTIV

SecurityOCX / OncoCyte Corporation
InstitutionMillennium Management Llc
ManagerIsrael Englander
Latest Disclosed Ownership103,470 shares
Latest Disclosed Value $ 339,382
Millennium Management Llc reports 68.58% increase in ownership of OCX / OncoCyte Corporation

On May 15, 2026 - Millennium Management Llc filed a 13F-HR form disclosing ownership of 103,470 shares of OncoCyte Corporation (US:OCX) valued at $339,382 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 61,377 shares of OncoCyte Corporation. This represents a change in shares of 68.58% during the quarter. The current value of the position is $331,104 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F INSIGHT MOLECULAR DIA COM NEW 68235C206 103,470 42,093 68.58 339 -26.30 0.0001
2026-02-17 2025-12-31 13F INSIGHT MOLECULAR DIA COM NEW 68235C206 61,377 -11,914 -16.26 460 89.30 0.0002
2025-11-14 2025-09-30 13F INSIGHT MOLECULAR DIA COM NEW 68235C206 73,291 55,781 318.57 243 367.31 0.0001
2025-08-14 2025-06-30 13F INSIGHT MOLECULAR DIA COM NEW 68235C206 17,510 4,106 30.63 53 26.83 0.0000
2025-05-15 2025-03-31 13F ONCOCYTE COM NEW 68235C206 13,404 13,404 41 0.0000
2024-02-14 2023-12-31 13F ONCOCYTE COM NEW 68235C206 0 -14,754 -100.00 0 -100.00
2023-11-14 2023-09-30 13F ONCOCYTE COM NEW 68235C206 14,754 14,754 48 0.0000
2023-08-14 2023-06-30 13F ONCOCYTE COM 68235C107 337,765 -136,946 -28.85 78 0.0000
2023-05-15 2023-03-31 13F ONCOCYTE COM 68235C107 474,711 -86,650 -15.44 168 -100.00 0.0001
2023-02-14 2022-12-31 13F ONCOCYTE COM 68235C107 561,361 -160,025 -22.18 180 -65.84 0.0001
2022-11-14 2022-09-30 13F ONCOCYTE COM 68235C107 721,386 -274,783 -27.58 527 -41.18 0.0003
2022-08-15 2022-06-30 13F ONCOCYTE COM 68235C107 996,169 996,169 896 0.0006
2022-05-16 2022-03-31 13F ONCOCYTE COM 68235C107 0 -141,064 -100.00 0 -100.00
2022-02-14 2021-12-31 13F ONCOCYTE COM 68235C107 141,064 -158,108 -52.85 306 -71.27 0.0002
2021-11-15 2021-09-30 13F ONCOCYTE COM 68235C107 299,172 -236,388 -44.14 1,065 -65.35 0.0006
2021-08-16 2021-06-30 13F ONCOCYTE COM 68235C107 535,560 -49,218 -8.42 3,074 1.29 0.0019
2021-05-17 2021-03-31 13F ONCOCYTE COM 68235C107 584,778 527,032 912.67 3,035 2,099.28 0.0022
2021-02-16 2020-12-31 13F ONCOCYTE COM 68235C107 57,746 17,415 43.18 138 146.43 0.0001
2020-11-16 2020-09-30 13F ONCOCYTE COM 68235C107 40,331 40,331 56 0.0001
2020-02-14 2019-12-31 13F ONCOCYTE COM 68235C107 0 -50,061 -100.00 0 -100.00
2019-11-14 2019-09-30 13F ONCOCYTE COM 68235C107 50,061 -39,185 -43.91 105 -52.70 0.0002
2019-08-15 2019-06-30 13F/A-1 ONCOCYTE COM 68235C107 89,246 -139,286 -60.95 222 -75.42 0.0003
2019-08-14 2019-06-30 13F SCPHARMACEUTICALS COM 68235C107 33,780 -194,752 108
2019-05-14 2019-03-31 13F ONCOCYTE COM 68235C107 228,532 196,949 623.59 903 1,043.04 0.0014
2018-11-14 2018-09-30 13F ONCOCYTE COM 68235C107 31,583 -92,229 -74.49 79 -75.00 0.0001
2018-08-14 2018-06-30 13F ONCOCYTE COM 68235C107 123,812 123,812 316 0.0004
2017-08-14 2017-06-30 13F ONCOCYTE COM 68235C107 0 -26,343 -100.00 0 -100.00
2017-05-15 2017-03-31 13F ONCOCYTE COM 68235C107 26,343 26,343 157 0.0003
2016-08-15 2016-06-30 13F ONCOCYTE COM 68235C107 0 -10,721 -100.00 0 -100.00
2016-05-16 2016-03-31 13F ONCOCYTE COM 68235C107 10,721 10,721 49 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.